JPRN-UMIN000014625已完成未知
For advanced or recurrent esophageal cancer Of combination therapy - docetaxel-cisplatin-5 fluorouracil phase I/II trial - Bi-weekly DCF therapy for esophageal cancer PI/II study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Cases with (heart disease, interstitial pneumonitis or pulmonary fibrosis, and cirrhosis of the liver) complications serious. patients with serious infections Patients with edema required Treatment Cases with non-pleural effusion control, ascites Patients with a history of drug hypersensitivity serious. Cases there is a possibility that pregnant women, pregnant and lactating women. Cases is determined participation in the test is difficult and complicated by psychiatric symptoms or psychosis Patients undergoing (oral or intravenous) systemic continuous administration ofsteroid Cases attending physician was deemed inappropriate In carrying out Other, this clinical trial.
研究者
相似试验
招募中
3 期
Management of advanced esophageal cancer patients received chemotherapy using early ctDNA dynamicsEsophageal cancerJPRN-UMIN000047559Division of Biomedical Research and Development, Institute of Biomedical Sciences, Iwate Medical University60
尚未招募
不适用
Prospective Multicenter Observational Study of Esophageal Preservation Survival in definitive Chemoradiotherapy +/- Photodynamic Therapy for Esophageal CancerEsophageal CancerJPRN-UMIN000043767agoya University150
已完成
不适用
Study of treatment for esophageal cancerEsophageal cancerJPRN-UMIN000040909Graduate School of Medical Sciences,Kyushu University26
尚未招募
不适用
Clinical Outcomes in patients with Esophageal Cancer treated with Definitive ChemoradiotherapyCTRI/2021/03/032343one
尚未招募
1 期
Juzendaihoto administration for esophageal cancer patientsEsophageal cancerJPRN-UMIN000036616agasaki University35